Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Long-Term Deferred Tax: 2022

  • Therapeutics' Long-Term Deferred Tax was N/A to $39.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $39.3 million, marking a year-over-year change of. This contributed to the annual value of $39.3 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q4 2022, Therapeutics' Long-Term Deferred Tax is $39.3 million.
  • Therapeutics' Long-Term Deferred Tax's 5-year high stood at $39.3 million during Q4 2022, with a 5-year trough of $39.3 million in Q4 2022.
  • Moreover, its 1-year median value for Long-Term Deferred Tax was $39.3 million (2022), whereas its average is $39.3 million.